Target FGFR3 therapy(Onco3R Therapeutics BV)

N/A

Report date: 2025/11/04 10:59:14
NME

Base Information

Drug NameTarget FGFR3 therapy(Onco3R Therapeutics BV)
Drug Alias NameFGFR3
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptor 3 inhibitors
TargetsFibroblast growth factor receptor 3
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnco3R Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesOnco3R Therapeutics BV
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A